Clik here to view.
NEC’s AI Supports Doctors to Detect Neoplasia in Barrett’s Esophagus During...
TOKYO NEC Corporation (NEC; TOKYO: 6701) today announced the development of an AI technology for supporting doctors to detect neoplasia in Barrett’s esophagus during endoscopic procedures. This is...
View ArticleClik here to view.
NEC的人工智能技术帮助医生在内镜检查时检出巴雷特食管肿瘤
东京 (美国商业资讯)–NEC Corporation (NEC; TOKYO: 6701)今天宣布开发一项人工智能(AI)技术，以帮助医生在内镜检查时检出巴雷特(Barrett)食管肿瘤。这是世界首创的符合欧洲安全、健康和环保标准(*1) CE认证标志要求的技术，以WISE VISION®内镜形式发布，将很快在欧洲上市，用于帮助医生检出巴雷特肿瘤(*2)。...
View ArticleClik here to view.
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution...
MELBOURNE, Australia Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations...
View ArticleClik here to view.
BeiGene Announces First Presentation of the Phase 3 ALPINE Trial Comparing...
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced...
View ArticleClik here to view.
Benefits in a Pandemic: NaturalVue® Offers Multiple Solutions for Patients...
ATLANTA US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses (‘NaturalVue MF’) Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’,...
View ArticleClik here to view.
DentalMonitoring凭借适用于所有品牌牙套和矫正器的AI驱动解决方案，不断颠覆正畸市场
得克萨斯州奥斯汀 (美国商业资讯)–该公司引领虚拟正畸领域，自2014年以来一直是市场领导者。公司正通过唯一市售的基于AI的虚拟监测解决方案再次颠覆该行业，该解决方案适用于所有类型和品牌的矫正器和牙套治疗。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20210602005424/zh-CN/ Taking a...
View ArticleClik here to view.
Clik here to view.
デンタル・モニタリング、あらゆるブランドのブラケットおよびアライナーに対応したAI搭載ソリューションにより、歯列矯正市場に根本的な変革をもたらし続ける
米テキサス州オースティン （ビジネスワイヤ）– 仮想歯列矯正分野の草分けとして2014年から市場リーダー企業となってきた当社が、あらゆるタイプやブランドのアライナーおよびブラケットによる治療に適用できる唯一の市販AIベース仮想モニタリングソリューションにより、再び業界に大変革をもたらしています。...
View ArticleClik here to view.
Sesen Bio Announces Global Supply Partnership with Qilu Pharmaceutical
CAMBRIDGE, Mass. Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that on Tuesday,...
View ArticleClik here to view.
Veristat Appoints Colleen Pelton Chief Talent Officer
SOUTHBOROUGH, Mass. Veristat, a scientific-minded global clinical research organization (CRO), announced the appointment of Colleen Pelton to the role of Chief Talent Officer. Ms. Pelton joins...
View ArticleClik here to view.
Preclinical Studies From Vaxxas and Collaborators Reveal Potential of Vaxxas’...
CAMBRIDGE, Mass. & BRISBANE, Australia Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced that research demonstrating the potential of...
View ArticleClik here to view.
IASO Receives NMPA Acceptance of its First Indication IND Application for...
PLEASANTON, Calif. & NANJING, China IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and...
View ArticleClik here to view.
Guangzhou Bio-Gene Announces Oral Presentation at the 2021 ASCO Annual Meeting
GUANGZHOU, China Guangzhou Bio-Gene, a clinical-stage biopharmaceutical company developing a pipeline of innovative oncology therapies, today announced the company will present at the 2021 American...
View ArticleClik here to view.
Cardiac Insight Announces Expansion Into More Than 20 Asia-Pacific Markets...
BELLEVUE, Wash. & SEONGNAM, South Korea Cardiac Insight, Inc., a digital health innovator specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis software...
View ArticleClik here to view.
アビオメッド、心不全患者の予後を改善する画期的な医療機器メーカーpreCARDIA社を買収
米マサチューセッツ州ダンバース （ビジネスワイヤ） — アビオメッド（NASDAQ:...
View ArticleClik here to view.
CORRECTING and REPLACING IASO Receives NMPA Acceptance of its First...
PLEASANTON, Calif. & NANJING, China First sentence of release should read: “…has been accepted by the China National Medical Products Administration (NMPA)…” (instead of “…has been approved by...
View ArticleClik here to view.
Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their...
SAN DIEGO Today Invivoscribe, a global leader in precision diagnostics, announced the launch of a new 12-color multiparametric flow cytometry service in Shanghai, China, the newest reference...
View ArticleClik here to view.
Biolog-id to Strengthen Its Presence in India by Opening a Registered Office
PARIS Biolog-id, a global service provider of connected healthcare solutions, announces today the opening of a registered office in the capital city of India, New Delhi. By creating this hub,...
View ArticleClik here to view.
Patritumab Deruxtecan Data at ASCO Demonstrates Tumor Response Across...
TOKYO, MUNICH & BASKING RIDGE, N.J. New data from Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo’s) patritumab deruxtecan (HER3-DXd), a HER3 directed antibody drug conjugate (ADC),...
View ArticleClik here to view.
クラウン・バイオサイエンス、大規模スクリーニングパネルを実現するため、ATCCおよびNIHの定評ある細胞株に対する優先アクセスを発表
サンディエゴ （ビジネスワイヤ） —...
View Article